Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

Developing a Humanised Chimeric Retinal Organoid Model to Study New Cell Therapies for Inherited Retinal Diseases

EF 2023-24

Résumé
Inherited retinal diseases (IRDs) are blinding eye conditions that affect approximately 85,000 Canadians and cost society $1.6¬-6.7 billion annually. Light-sensitive cells in the retina, called photoreceptors, progressively degenerate, leading to permanent blindness. There are currently no cures-but stem cell therapy holds exciting promise. In this approach, healthy cells from human donors are injected into a patient's eye, replacing and repairing diseased photoreceptors. To advance the discovery of effective treatments, a new, human-based model in which to evaluate stem cell therapy is needed, as commonly used animal models do not faithfully mimic the human IRD condition. Retinal organoids are 3D retinas grown in a Petri dish from human stem cells, induced to develop into mature tissue. As a model of human disease, organoids are ideal for use in pre-clinical treatment discovery. My project aims to develop a novel retinal organoid model to investigate the interactions between diseased host cells and healthy donor cells that promote vision restoration. By combining healthy stem cells and IRD patient-derived stem cells together, I will create mixed-cell retinal organoids, whereby the healthy and diseased cells integrate within the same environment, reflecting what may happen after cell transplantation in a patient retina. Throughout organoid development, I will analyze the health of organoid photoreceptors and evaluate potential structural and genetic changes that may be influenced by the interaction of the healthy cells with diseased cells. Creation of this innovative model will allow me to obtain new insight into donor-host cell interactions and mechanisms of photoreceptor rescue in a diseased retinal environment. This will provide a key step in understanding retinal stem cell transplantation and furthering the discovery of cures for IRDs.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
496578
Name
Ashworth Kristen E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Developing a Humanised Chimeric Retinal Organoid Model to Study New Cell Therapies for Inherited Retinal Diseases
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Blindness; Cell Engraftment; Donor-Host Cell Interactions; Inherited Retinal Disease; Organoids; Photoreceptors; Retina; Stem Cell Therapy
Abstract
Inherited retinal diseases (IRDs) are blinding eye conditions that affect approximately 85,000 Canadians and cost society $1.6¬-6.7 billion annually. Light-sensitive cells in the retina, called photoreceptors, progressively degenerate, leading to permanent blindness. There are currently no cures-but stem cell therapy holds exciting promise. In this approach, healthy cells from human donors are injected into a patient's eye, replacing and repairing diseased photoreceptors. To advance the discovery of effective treatments, a new, human-based model in which to evaluate stem cell therapy is needed, as commonly used animal models do not faithfully mimic the human IRD condition. Retinal organoids are 3D retinas grown in a Petri dish from human stem cells, induced to develop into mature tissue. As a model of human disease, organoids are ideal for use in pre-clinical treatment discovery. My project aims to develop a novel retinal organoid model to investigate the interactions between diseased host cells and healthy donor cells that promote vision restoration. By combining healthy stem cells and IRD patient-derived stem cells together, I will create mixed-cell retinal organoids, whereby the healthy and diseased cells integrate within the same environment, reflecting what may happen after cell transplantation in a patient retina. Throughout organoid development, I will analyze the health of organoid photoreceptors and evaluate potential structural and genetic changes that may be influenced by the interaction of the healthy cells with diseased cells. Creation of this innovative model will allow me to obtain new insight into donor-host cell interactions and mechanisms of photoreceptor rescue in a diseased retinal environment. This will provide a key step in understanding retinal stem cell transplantation and furthering the discovery of cures for IRDs.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ashworth, Kristen E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~